Safety and efficacy of Vitamin D


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
29 08 2023
Historique:
medline: 31 8 2023
pubmed: 30 8 2023
entrez: 29 8 2023
Statut: epublish

Résumé

The study aimed to compare early molecular response (EMR) rates at 3 months of imatinib therapy with and without vitamin D Double-blind, placebo-controlled, exploratory randomised trial. Tertiary care hospital in northern India. Treatment-naive patients with chronic phase chronic myeloid leukaemia (n=62) aged >12 years were recruited from January 2020 to January 2021. Patients with progressive disease, pregnancy and hypercalcaemia were excluded. Oral vitamin D The primary outcome was to compare EMR (defined as At baseline, 14.5% of the patients had normal vitamin D Vitamin D CTRI/2019/09/021164.

Identifiants

pubmed: 37643857
pii: bmjopen-2022-066361
doi: 10.1136/bmjopen-2022-066361
pmc: PMC10465917
doi:

Substances chimiques

Imatinib Mesylate 8A1O1M485B
Cholecalciferol 1C6V77QF41

Types de publication

Randomized Controlled Trial Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e066361

Informations de copyright

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Indian J Med Paediatr Oncol. 2013 Jul;34(3):159-63
pubmed: 24516298
J Family Med Prim Care. 2019 Jul;8(7):2450-2455
pubmed: 31463275
Int J Hematol. 2016 Jan;103(1):70-8
pubmed: 26547571
Leukemia. 2002 Sep;16(9):1579-83
pubmed: 12200666
Mol Med Rep. 2015 Apr;11(4):3143-7
pubmed: 25501030
Blood. 2008 Mar 1;111(5):2538-47
pubmed: 18042796
Am J Public Health. 2006 Feb;96(2):252-61
pubmed: 16380576
Blood. 2013 Jun 13;121(24):4867-74
pubmed: 23620574
Intern Emerg Med. 2018 Dec;13(8):1337-1339
pubmed: 30255465
Cancers (Basel). 2013 Mar 11;5(1):255-80
pubmed: 24216707
Ann Hematol. 2015 Apr;94 Suppl 2:S107-21
pubmed: 25814077
Leukemia. 2014 Oct;28(10):1988-92
pubmed: 24798484
Am J Hematol. 2014 Jun;89(6):626-32
pubmed: 24619861
Hematology. 2011 Sep;16(5):278-83
pubmed: 21902891
Cancers (Basel). 2022 Sep 26;14(19):
pubmed: 36230609
Mayo Clin Proc. 2015 Oct;90(10):1440-54
pubmed: 26434969
Ann Hematol. 2021 Jan;100(1):85-96
pubmed: 33025163
Blood. 2014 Jan 23;123(4):494-500
pubmed: 24311723

Auteurs

Arkapal Bandyopadhyay (A)

Department of Pharmacology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India.

Sarika Palepu (S)

Community Medicine and Family Medicine, All India Institute of Medical Sciences, Kalyani, West Bengal, India.

Puneet Dhamija (P)

Department of Pharmacology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India.

Uttam Kumar Nath (UK)

Department of Medical Oncology Haematology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India.

Rituparna Chetia (R)

Department of Medical Oncology Haematology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India.

Anamika Bakliwal (A)

Department of Medical Oncology Haematology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India.

Sudeep Vaniyath (S)

Department of Medical Oncology Haematology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India.

Debranjani Chattopadhyay (D)

Department of Medical Oncology Haematology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India.

Shailendra Handu (S)

Department of Pharmacology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India shailendra.phar@aiimsrishikesh.edu.in.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH